Infertility of Tubal OriginNCT05209542
Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility
A study testing Hysterosalpingo-Foam Ultrasonography and Laparoscopy in people with Infertility of Tubal Origin, run by Cairo University at 1 site in Egypt.
Trial summary
Women presenting with primary or secondary infertility and are undergoing investigation of tubal patency assessment will be subjected to: The examination is performed between days 5 and 10 of the menstrual cycle. Read more about this study
- Who is it for?
- Ages 20 to 40 years, women only
- Conditions the study is for
- Infertility of Tubal Origin
- What is being tested?
- Hysterosalpingo-Foam Ultrasonography and Laparoscopy
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 119 participants
- Where
- 1 siteEgypt
- Study dates
- 9 Feb 2018to 3 Apr 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Sexually active women in the reproductive age group between 20 and 40 years
- History of primary or secondary infertility ( either unexplained or suspected tubal factor by history taking )
- Tubal factor has not been investigated before or has been investigated with inconclusive results
Who cannot join
- Age less than 20 or above 40 years.
- Using contraception.
- Undiagnosed pregnancy.
- known allergy to lidocaine.
- active pelvic inflammatory disease or genital tract bleeding.
- Patent both tubes as assessed previously ( no need for exposure to further Investigation.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility, (a Cross-sectional Study).
Women presenting with primary or secondary infertility and are undergoing investigation of tubal patency assessment will be subjected to:
- The examination is performed between days 5 and 10 of the menstrual cycle.
- Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure
- Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvis
- The cervix is to be visualized with a Cusco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter.
- Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
- Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection.
- Tubal patency and quality of visualization are classified according the following parameters:
Read more
- Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency.
- Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency.
- Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion.
- Technical difficulty making tubal evaluation impossible
- Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
Read the detailed description
Women in the reproductive age group between 20 and 40 years old presenting with primary or secondary infertility ( either unexplained or suspected tubal factor by history taking ) and are undergoing investigation of tubal patency assessment
Each patient in this study will be subjected to:
- The examination is performed between days 5 and 10 of the menstrual cycle, the patient in gynecological position, preferably with the aid of one assistant.
- Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure
- Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvic organs is to be performed using Samsung Elite with endovaginal probe of frequency 6-12 MHz
- The cervix is to be visualized with a Cussco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter.
- The foam contrast agent is created by combining 3-4mL of 2% lidocaine gel 12-13mL of saline and 3mL air.
- The assistant creates the foam immediately before application, moving the mixture between two connected 20-mL syringes, until a whitish suspension is obtained (approximately 10-20 times).
- Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
- Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection.
- Acquisition without Doppler usually takes less than 5 s, while acquisition with power Doppler is longer(approximately 10 s)
- After dataset acquisition, Images will be stored as 2D still images, 2D clips +/- 3D volumes. the patient is to be discharged and final diagnosis is made based on the real-time observations and, if available, offline analyses of acquired datasets.
- Tubal patency and quality of visualization are classified according the following parameters:
- Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency.
- Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency.
- Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion.
- Technical difficulty making tubal evaluation impossible e.g. absent filling of the endometrial cavity due to backflow of contrast, inability to introduce the catheter into the cervical os or maintain the catheter in the correct position preventing instillation of contrast into the endometrial cavity.
- Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
- The raters are to be blinded to the results of the ultrasound examination until endoscopic diagnosis is to be performed
- Comparison between the results of the above mentioned techniques will be done and statistical analysis of the results will be carried out
- Conditions
- Infertility of Tubal Origin
- Being tested
- Hysterosalpingo-Foam Ultrasonography, Laparoscopy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hysterosalpingo-Foam UltrasonographyProcedure or surgery
- Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
- Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection
LaparoscopyProcedure or surgery
- Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia
| Study group | Role | What they receive |
|---|---|---|
| Hysterosalpingo-Foam Ultrasonography | Active comparator | 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging Receives: Procedure: Hysterosalpingo-Foam Ultrasonography; Procedure: Laparoscopy |
| laparoscopy | Active comparator | • Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia Receives: Procedure: Hysterosalpingo-Foam Ultrasonography; Procedure: Laparoscopy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Tubal patency
To evaluate the accuracy of Hysterosalpingo-Foam Sonography combined with Power Doppler in assessment of tubal patency in infertile women
Measured: During the ultrasound
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2022
- Study start9 Feb 2018
- Primary completion17 Feb 2020
- Study completion3 Apr 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Infertility of Tubal OriginStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 119 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed M Maged, MD, Cairo University
- Investigators
- Ahmed Mohamed Maged M ElGoly, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05209542
- Sponsor's protocol ID
- 63
- Status last verified
- Jan 2022
- First submitted
- 13 Jan 2022
- Last updated
- 26 Jan 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility, (a Cross-sectional Study).
- ClinicalTrials.gov ID
- NCT05209542
- Acronym / sponsor ID
- 63
- Conditions
- Infertility of Tubal Origin
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 119 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 9 Feb 2018 (actual)
- Primary completion
- 17 Feb 2020 (actual)
- Study completion
- 3 Apr 2021 (actual)
- First posted
- 26 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Women presenting with primary or secondary infertility and are undergoing investigation of tubal patency assessment will be subjected to:
- The examination is performed between days 5 and 10 of the menstrual cycle.
- Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure
- Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvis
- The cervix is to be visualized with a Cusco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter.
- Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
- Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection.
- Tubal patency and quality of visualization are classified according the following parameters:
- Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency.
- Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency.
- Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion.
- Technical difficulty making tubal evaluation impossible
- Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
Detailed description
Women in the reproductive age group between 20 and 40 years old presenting with primary or secondary infertility ( either unexplained or suspected tubal factor by history taking ) and are undergoing investigation of tubal patency assessment
Each patient in this study will be subjected to:
- The examination is performed between days 5 and 10 of the menstrual cycle, the patient in gynecological position, preferably with the aid of one assistant.
- Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure
- Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvic organs is to be performed using Samsung Elite with endovaginal probe of frequency 6-12 MHz
- The cervix is to be visualized with a Cussco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter.
- The foam contrast agent is created by combining 3-4mL of 2% lidocaine gel 12-13mL of saline and 3mL air.
- The assistant creates the foam immediately before application, moving the mixture between two connected 20-mL syringes, until a whitish suspension is obtained (approximately 10-20 times).
- Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
- Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection.
- Acquisition without Doppler usually takes less than 5 s, while acquisition with power Doppler is longer(approximately 10 s)
- After dataset acquisition, Images will be stored as 2D still images, 2D clips +/- 3D volumes. the patient is to be discharged and final diagnosis is made based on the real-time observations and, if available, offline analyses of acquired datasets.
- Tubal patency and quality of visualization are classified according the following parameters:
- Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency.
- Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency.
- Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion.
- Technical difficulty making tubal evaluation impossible e.g. absent filling of the endometrial cavity due to backflow of contrast, inability to introduce the catheter into the cervical os or maintain the catheter in the correct position preventing instillation of contrast into the endometrial cavity.
- Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
- The raters are to be blinded to the results of the ultrasound examination until endoscopic diagnosis is to be performed
- Comparison between the results of the above mentioned techniques will be done and statistical analysis of the results will be carried out
Study design
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Hysterosalpingo-Foam Ultrasonography | Active comparator | Procedure: Hysterosalpingo-Foam Ultrasonography, Procedure: Laparoscopy3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging |
| laparoscopy | Active comparator | Procedure: Hysterosalpingo-Foam Ultrasonography, Procedure: Laparoscopy• Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Sexually active women in the reproductive age group between 20 and 40 years
- History of primary or secondary infertility ( either unexplained or suspected tubal factor by history taking )
- Tubal factor has not been investigated before or has been investigated with inconclusive results
Key exclusion criteria (6 listed)
- Age less than 20 or above 40 years.
- Using contraception.
- Undiagnosed pregnancy.
- known allergy to lidocaine.
- active pelvic inflammatory disease or genital tract bleeding.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hysterosalpingo-Foam Ultrasonography* Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging * Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection | Procedure or surgery | Hysterosalpingo-Foam Ultrasonography, laparoscopy |
| Laparoscopy• Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia | Procedure or surgery | Hysterosalpingo-Foam Ultrasonography, laparoscopy |
Primary outcome
Tubal patency
Time frame: During the ultrasound
To evaluate the accuracy of Hysterosalpingo-Foam Sonography combined with Power Doppler in assessment of tubal patency in infertile women
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Infertility of Tubal Origin
Not yet recruiting
Clinical Evaluation of a Tubal Selective Delivery System
Infertility of Tubal Origin
Recruiting
In Vitro Maturation of Human Eggs
Healthy, PCOS
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ahmed Mohamed Maged M ElGoly principal investigator
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hysterosalpingo-Foam Ultrasonography and Laparoscopy in people with Infertility of Tubal Origin, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Tubal patency (time frame: During the ultrasound). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2022.